Hadeel Abdul Elah Ibrahim *, Mohammed Omer Mohammed ** and Kawa Abdulla Mahmood ***

*    College of Nursing, University of Sulaimani.

**  Department of Medicine, College of Medicine, University of Sulaimani.

*** Department of Surgery, College of Medicine, University of Sulaimani.

Submitted: 12/1/2016; Accepted: 29/6/2016; Published: 1/12/2016

DOI Link: https://doi.org/10.17656/jsmc.10097



Helicobacter pylori (H. pylori) infection in gastric mucosa may cause systemic inflammatory reaction, which increases risk of cardiovascular disease and atherosclerosis. 


This study aimed to assess the association between H. pylori infection and serum high sensitivity C-reactive protein (hsCRP), and carotid intima media thickness.

Patients and Methods

This is a case control study, conducted at Kurdistan center for Gastroenterology & Hepatology from Dec. 2012 to March 2014. One hundred patients with dyspepsia and positive H. pylori. 75 (39 males and 36 females) non dyspeptic apparently healthy subject with H. pylori negative as control group were assessed. The serum sample tested for H. pylori infection and Hs-CRP using ELISA and stool sample examined by using Rapid Immunoassay method to detect H. pylori antigens.


The mean hs-CRP level was significantly different (P<0.01) between patients and controls. A significant correlation between different tests of H. pylori and hs-CRP level was found (p < 0.01). A significant correlation was found between hs-CRP level and internal carotid artery (ICA), common carotid artery (CCA) thickness in patients (p < 0.01).


H. pylori infection was significantly associated with higher serum hs-CRP.There was significant correlation between hs-CRP and carotid intima-media thickness.


H. pylori, hs-CRP, Carotid Thickness, Sulaimani.


1. Ballantyne CM, Nambi V. (2005): Markers of inflammation and their clinical significance. Atheroscler Suppl. 6(2):21-9.

2. Chen M, Chen C, Wu CYC, Fang C, Chang YHH. (2007): Interleukin- 18: a strong predictor of the extent of coronary artery disease in patients with unstable angina. Heart Vessels. 22:371–375.

3. Mouridsen MR, Nielsen OW, Carlsen CM, Mattsson N, Ruwald MH, Binici Z, Sajadieh A. (2014): High-sensitivity C-reactive protein and exercise-induced changes in subjects suspected of coronary artery disease J Inflamm Res. 21; 7:45-55.

4. Kastelein JJ, Wiegman A, Groot E. (2003): Surrogate markers of atherosclerosis: impact of statins. Atheroscler Suppl. 4:31-6.

5. Ridker PM. (2001): High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 103: 1813e8. 

6. Wolf SC, Brehm BR, Mayer O, Ju¨rgens S, Schultze G. Risler.( 2004): T Infectious risk for atherosclerotic vascular disease in hemodialysis patients e Chlamydia pneumoniae but not Helicobacter pylori or cytomegalovirus is associated with increased Creactive protein. Ren Fail 26:279e87.

7. Nuzhat RS, Garvey TW, Khaled MA (2009) : Helicobacter pylori -induced higher C-reactive protein in obese African Americans Artery Research. 3, 39e42.

8. Kanbay M, Kasapoglu B, Turgut F, Uz E, Bavbek N, Akcay A. (2007):Helicobacter pylori: a major risk factor for endothelial dysfunction. Med Hypotheses, 69:227e8.

9. Stenström B, Mendis A, Marshall B (2008): “Helicobacter pylori-The latest in diagnosis and treatment”. Aust Fam Physician 37 (8): 608–12.

10 Mancia G., Fagard R., Narkiewicz K., Redon J, Zanchetti A, Böhm M, etal. (2013): ESH/ESC Guidelines for the management of arterial hypertension European Heart Journal 34; 2159–2219

11. Jafarzadeh  A, Hassanshahi G. H. , Nemati  M. (2009) : Serum Levels of High-Sensitivity C-Reactive Protein (hs-CRP) in Helicobacter pylori-Infected Peptic Ulcer Patients and Its Association with Bacterial CagA Virulence Facto. Dig Dis Sci . 54:2612–2616. (IVSL).

12. Al Fawaeir S and Abu Zaid MB. (2013): Serum level hs- C-reactive protein in Helicobacter pylori infected patients J Investig Biochem. 2(1):32-36.

13. Kanbay M, Gur G, Arslan H, Yilmaz U, Boyacioglu S (2005). The relationship of ABO blood group, age, gender, smoking, and Helicobacter pylori infection. Dig Dis Sci, 50, 1214-7.

14. Kebapcilar L, Bilgir O, Cetinkaya E, Akyol M, Bilgir F, Bozkaya G.( 2010):The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levelsClinics (Sao Paulo). 65(8):799-802.

15. Singh SK, Suresh MV, Voleti B, Agrawal A. (2008): The connection between C-reactive protein and atherosclerosis. Ann Med. 40(2):110–120. 

16. Jha H Ch, Prasad J, MittalA. (2008): High immunoglobulin A seropositivity for combined Chlamydia Pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker Heart Vessels. 23:390–396.

17.Black S, Kushner I, Samols D. (2004): C-reactive protein. J Biol Chem. 279:48487-90.

18. Corrado E, Novo S. (2005): Role of inflammation and infection in vascular disease. Acta Chir Belg. 105:567-79.

19. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al .(2004): C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 350:1387-97.

20. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al.( 2004): Inflammatory markers and risk of coronary heart disease in men and women. N Engl J Med 351:2599-610.

21. Vahdat K, Jafari SM, Pazoki R, Nabipour I. (2007): Concurrent increased high sensitivity C-reactive protein and chronic infections are associated with coronary artery disease: A population-based study. Indian J Med Sci. 61:135-43.

22. Wilson AM, Ryan MC, Boyle AJ. (2006): The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol. 106:291–297.

23. Yamaoka-Tojo M, Tojo T, Machida TMY, Kitano Y, Izumi TKT. (2003): C-reactive protein-induced production of interleukin-18 in human endothelial cells: a mechanism of orchestrating cytokine cascade in acute coronary syndrome. Heart Vessels 18:183– 187.

24. Jafarzadeh A, Esmaeeli-Nadimi A, Shariati M. (2008): High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease. Iran J Immunol. 5(1):51–56. 

25. Vojdani A (2003) :A look at infectious agents as a possible causative factor in cardiovascular disease: part I. Lab Med 34(3): 203–212.

Full Text

 © The Authors, published by University of Sulaimani, College of Medicine

This work is licensed under a Creative Commons Attribution 4.0 International License.